Hadar Kolb - Search Results

Year	Number of Results
2013	1
2015	1
2016	3
2017	1
2018	1
2019	3
2021	5
2022	5
2023	3
2024	2

1

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.

Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, Ohayon J, Wu T, Cortese ICM, Reich DS. Absinta M, et al. Among authors: kolb h. JAMA Neurol. 2019 Dec 1;76(12):1474-1483. doi: 10.1001/jamaneurol.2019.2399. JAMA Neurol. 2019. PMID: 31403674 Free PMC article.

2

From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions.

Kolb H, Al-Louzi O, Beck ES, Sati P, Absinta M, Reich DS. Kolb H, et al. Neuroimage Clin. 2022;36:103194. doi: 10.1016/j.nicl.2022.103194. Epub 2022 Sep 14. Neuroimage Clin. 2022. PMID: 36170753 Free PMC article. Review.

3

Olfactory function in Susac syndrome.

Piura Y, Karni A, Kolb H, Vigiser I, Regev K. Piura Y, et al. Among authors: kolb h. Clin Neurol Neurosurg. 2023 Oct;233:107909. doi: 10.1016/j.clineuro.2023.107909. Epub 2023 Jul 20. Clin Neurol Neurosurg. 2023. PMID: 37524045

4

New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis.

Segal Y, Nisnboym M, Regev K, Arnon K, Kolb H, Fahoum F, Aizenstein O, Paran Y, Louzoun Y, Israeli S, Loewenthal R, Svetlitzky N, Alcalay Y, Raphael I, Gadoth A. Segal Y, et al. Among authors: kolb h. Neurol Neuroimmunol Neuroinflamm. 2023 Mar 27;10(3):e200103. doi: 10.1212/NXI.0000000000200103. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36973076 Free PMC article.

5

Smartphone-based gait assessment for multiple sclerosis.

Regev K, Eren N, Yekutieli Z, Karlinski K, Massri A, Vigiser I, Kolb H, Piura Y, Karni A. Regev K, et al. Among authors: kolb h. Mult Scler Relat Disord. 2024 Feb;82:105394. doi: 10.1016/j.msard.2023.105394. Epub 2023 Dec 20. Mult Scler Relat Disord. 2024. PMID: 38141562

6

The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis.

Ben-Shalom I, Karni A, Kolb H. Ben-Shalom I, et al. Among authors: kolb h. Int J Mol Sci. 2021 Dec 31;23(1):474. doi: 10.3390/ijms23010474. Int J Mol Sci. 2021. PMID: 35008899 Free PMC article. Review.

7

Role of immunosuppressive therapy for the treatment of multiple sclerosis.

Stankiewicz JM, Kolb H, Karni A, Weiner HL. Stankiewicz JM, et al. Among authors: kolb h. Neurotherapeutics. 2013 Jan;10(1):77-88. doi: 10.1007/s13311-012-0172-3. Neurotherapeutics. 2013. PMID: 23271506 Free PMC article. Review.

8

7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions.

Kolb H, Absinta M, Beck ES, Ha SK, Song Y, Norato G, Cortese I, Sati P, Nair G, Reich DS. Kolb H, et al. Ann Neurol. 2021 Oct;90(4):612-626. doi: 10.1002/ana.26194. Epub 2021 Sep 2. Ann Neurol. 2021. PMID: 34390015 Free PMC article.

9

CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.

Fuchs L, Mausner-Fainberg K, Luban A, Asseyer SE, Golan M, Benhamou M, Volovitz I, Regev K, Vigiser I, Piura Y, Kolb H, Paul F, Karni A. Fuchs L, et al. Among authors: kolb h. J Neuroimmunol. 2022 Oct 15;371:577936. doi: 10.1016/j.jneuroim.2022.577936. Epub 2022 Jul 28. J Neuroimmunol. 2022. PMID: 35926331

10

Real-World experience with efgartigimod in patients with myasthenia gravis.

Fuchs L, Shelly S, Vigiser I, Kolb H, Regev K, Schwartzmann Y, Vaknin-Dembinsky A, Dori A, Karni A. Fuchs L, et al. Among authors: kolb h. J Neurol. 2024 Mar 25. doi: 10.1007/s00415-024-12293-5. Online ahead of print. J Neurol. 2024. PMID: 38528163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year